X0508 4 2026-02-18 0001551152 AbbVie Inc. ABBV 0001951400 Siatis Perry C 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 false true false false EVP, GC AND SECRETARY 0 Common Stock, $0.01 par value 2026-02-18 4 A 0 16290 0 A 20909 D Common Stock, $0.01 par value 2026-02-18 4 A 0 5792 0 A 26701 D Common Stock, $0.01 par value 2026-02-18 4 A 0 5628 0 A 32329 D Common Stock, $0.01 par value 2026-02-18 4 A 0 5808 0 A 38137 D Option (Right to buy) 230.04 2026-02-18 4 A 0 19500 0 A 2036-02-17 Common Stock 19500 19500 D Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026. Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026. Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 15, 2024. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026. Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 13, 2025. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026. Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,500 on February 18, 2027, 6,500 on February 18, 2028, and 6,500 on February 18, 2029. /s/ T.O. Odutayo, Attorney-in-Fact for Perry C. Siatis 2026-02-20